The mechanism behind the degradation and modification of the highly complex mixture of ECM and IMF proteins is still not fully understood, however, studies indicate that the composition of MMPs and thereby the degradation products may differ between lung cancer subtypes 42–44. The gene discussed is MDFI; the disease is lung carcinoma.